The PE ratio for Ultralife stock stands at 24.19 as of Jun 13, 2025. This takes into account the latest EPS of $0.32 and stock price of $7.74. An increase of 38% has been observed in the PE ratio compared to its average of 17.6 of the last four quarters.
Over the last ten years, the average PE ratio of Ultralife has been 21.05. The current 24.19 P/E ratio is 15% higher than the historical average. Looking back at the last ten years, ULBI's PE ratio peaked in the Sep 2021 quarter at 39.56, with a price of $7.12 and an EPS of $0.18. The Dec 2018 quarter marked the lowest point at 4.3, with a price of $6.75 and an EPS of $1.57.
Maximum annual increase: 420.7% in 2019
Maximum annual decrease: -67.84% in 2018
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
2024 | 19.61 | 26.52% | $7.45 | $0.38 |
2023 | 15.5 | N/A | $6.82 | $0.44 |
2022 | N/A | N/A | $3.86 | -$0.01 |
2021 | N/A | N/A | $6.04 | -$0.01 |
2020 | 19.61 | -12.42% | $6.47 | $0.33 |
2019 | 22.39 | 420.7% | $7.39 | $0.33 |
2018 | 4.3 | -67.84% | $6.75 | $1.57 |
2017 | 13.37 | -37.87% | $6.55 | $0.49 |
2016 | 21.52 | -40.04% | $4.95 | $0.23 |
2015 | 35.89 | N/A | $6.46 | $0.18 |
2014 | N/A | N/A | $3.13 | -$0.12 |
2013 | N/A | N/A | $3.55 | -$0.05 |
2012 | N/A | N/A | $3.24 | -$0.09 |
2011 | N/A | N/A | $4.02 | -$0.12 |
2010 | N/A | N/A | $6.61 | -$0.36 |
Year | PE ratio | PE change | Price | EPS |
---|---|---|---|---|
Mar 2025 | 16.81 | -14.28% | $5.38 | $0.32 |
Dec 2024 | 19.61 | 19.28% | $7.45 | $0.38 |
Sep 2024 | 16.44 | -5.57% | $9.04 | $0.55 |
Jun 2024 | 17.41 | 26.43% | $10.62 | $0.61 |
Mar 2024 | 13.77 | -11.16% | $8.81 | $0.64 |
Dec 2023 | 15.5 | -60.3% | $6.82 | $0.44 |
Sep 2023 | 39.04 | 29.06% | $9.76 | $0.25 |
Jun 2023 | 30.25 | N/A | $4.84 | $0.16 |
Mar 2023 | N/A | N/A | $4.02 | -$0.02 |
Dec 2022 | N/A | N/A | $3.86 | -$0.01 |
Sep 2022 | N/A | N/A | $4.81 | -$0.06 |
Jun 2022 | N/A | N/A | $4.55 | -$0.09 |
Mar 2022 | N/A | N/A | $5.37 | -$0.07 |
Dec 2021 | N/A | N/A | $6.04 | -$0.01 |
Sep 2021 | 39.56 | 18.02% | $7.12 | $0.18 |
Currently, ULBI's PE ratio is higher than the 3, 5 and 10-year averages.
ULBI's PE ratio stands lower than its peer stock ENR, but it is higher than BDC's and ENS's. Ultralife is currently trading at a higher PE ratio (24.19) than its peers average of 17.72.
Stock name | PE ratio | Market cap |
---|---|---|
ENS EnerSys | 9.46 | $3.39B |
EPC EDGEWELL PERSONAL CARE Co | 13.39 | $1.09B |
BDC Belden Inc | 20.38 | $4.24B |
ULBI Ultralife Corp | 24.19 | $128.74M |
ENR Energizer Holdings Inc | 27.63 | $1.5B |
ULBI stock has a price to earnings ratio of 24.19 as of Jun 13, 2025.
Over the last 3 years, the average price to earnings ratio for ULBI stock is 21.1.
Over the last 5 years, the average price to earnings ratio for ULBI stock is 23.57.
Over the last ten years, the quarterly PE ratio reached its highest level at 39.56 in the Sep 2021 quarter.
ULBI's price to earnings ratio is currently 15% above its 10-year historical average.
To determine the P/E ratio, divide the latest stock price by the TTM earnings per share (EPS). As of today (Jun 13, 2025), Ultralife's share price is $7.74. The company's earnings per share for the trailing twelve months (TTM) ending Mar 2025 is $0.32. Therefore, Ultralife's PE ratio for today is 24.19. PE RATIO(24.19) = STOCK PRICE($7.74) / TTM EPS($0.32)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.